These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37587273)

  • 1. Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients.
    Abdo SM; Shousha WG; Mohamed AA; Elshobaky M; Saleh M; Ali MMA
    J Genet Eng Biotechnol; 2023 Aug; 21(1):85. PubMed ID: 37587273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
    Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A
    Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.
    Eldosoky MA; Hammad R; Elmadbouly AA; Aglan RB; Abdel-Hamid SG; Alboraie M; Hassan DA; Shaheen MA; Rushdi A; Ahmed RM; Abdelbadea A; Abdelmageed NA; Elshafei A; Ali E; Abo-Elkheir OI; Zaky S; Hamdy NM; Lambert C
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
    Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients.
    El-Ahwany EGE; Mourad L; Zoheiry MMK; Abu-Taleb H; Hassan M; Atta R; Hassanien M; Zada S
    Arch Med Sci; 2019 Oct; 15(6):1454-1461. PubMed ID: 31749873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
    Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
    Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and clinical implications in hepatocellular carcinoma.
    Mohamed AA; Ali-Eldin ZA; Elbedewy TA; El-Serafy M; Ali-Eldin FA; AbdelAziz H
    World J Hepatol; 2017 Aug; 9(23):1001-1007. PubMed ID: 28878865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma.
    Oura K; Fujita K; Morishita A; Iwama H; Nakahara M; Tadokoro T; Sakamoto T; Nomura T; Yoneyama H; Mimura S; Tani J; Kobara H; Okano K; Suzuki Y; Masaki T
    Oncol Lett; 2019 Jul; 18(1):882-890. PubMed ID: 31289566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC.
    Yosry A; Zayed N; Dawood RM; Ibrahim MK; Elsharkawy M; Ekladious SM; Khairy A; Elsharkawy A; Khairy M; Abdel Alem S; Bader El Din NG; El Awady MK; Abdellatif Z
    Lab Med; 2022 Sep; 53(5):523-529. PubMed ID: 35731638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis.
    El-Maraghy SA; Adel O; Zayed N; Yosry A; El-Nahaas SM; Gibriel AA
    J Adv Res; 2020 Mar; 22():57-66. PubMed ID: 31956442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
    Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
    Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
    Gui J; Tian Y; Wen X; Zhang W; Zhang P; Gao J; Run W; Tian L; Jia X; Gao Y
    Clin Sci (Lond); 2011 Mar; 120(5):183-93. PubMed ID: 20815808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.